Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-Life.

Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-Life.

Treatment efficacy and costs of anti-VEGF drugs have not been studied in clinical routine.To compare treatment costs and clinical outcomes of the medications when adjusting for patients' characteristics and clinical status.Comparative study.The largest public ophthalmologic clinic in Switzerlan...

Full description

Bibliographic Details
Main Authors: Martin K Schmid, Oliver Reich, Livia Faes, Sophie C Boehni, Mario Bittner, Jeremy P Howell, Michael A Thiel, Andri Signorell, Lucas M Bachmann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4524713?pdf=render

Internet

http://europepmc.org/articles/PMC4524713?pdf=render

Similar Items